Hepatitis A News and Research

RSS

Hepatitis A (formerly known as ''infectious hepatitis'') is an acute infectious disease of the liver caused by the hepatitis A virus (HAV), which is most commonly transmitted by the fecal-oral route via contaminated food or drinking water.

Many needle-stick injuries unreported

A survey of nearly 700 surgical residents in 17 U.S. medical centers finds that more than half failed to report needle-stick injuries involving patients whose blood could be a source of HIV, hepatitis and other infections.

28 Jun 2007

Hib vaccine could save hundreds of thousands of children in Asia

A new study from Bangladesh published online in The Pediatric Infectious Disease Journal shows that routinely vaccinating infants against H. influenzae type b (Hib), a bacterium that causes deadly Hib pneumonia and meningitis, could save hundreds of thousands of children in Asia.

28 Jun 2007

FDA fast tracks ViroPharma's treatment of hepatitis C

ViroPharma has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for HCV-796 for treatment of hepatitis C virus infection.

28 Jun 2007

Canada enhances capacity to fight infectious disease

Today representatives of all three levels of government and the Canada Foundation for Innovation turned the sod to launch construction of the International Vaccine Centre (InterVac) at the University of Saskatchewan, a $110.4-million project that will significantly enhance Canada's capacity to fight infectious disease in both animals and humans.

26 Jun 2007

Vaccine for human cytomegalovirus

Researchers at the University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences have patented a strategy for developing a human vaccine to prevent against Human Cytomegalovirus (hCMV) infection and disease.

23 Jun 2007

Entecavir can compromise HIV treatment

Treating hepatitis B patients with the drug entecavir can cause those who are also infected with HIV to become resistant to two of the most important drugs in the anti-HIV arsenal, according to a new report in the New England Journal of Medicine.

23 Jun 2007

Drug warning prompts treatment changes for those infected with hepatitis B and HIV

Cross-resistance alarms raised earlier this year by Johns Hopkins researchers about a widely used antiviral therapy for hepatitis B liver infections have prompted swift treatment revisions by the drug's maker and governmental agencies.

23 Jun 2007

Dutch research project designed to reduce maternal and child mortality

Top Institute Pharma, which carries out pioneering research projects with the support of the Dutch Ministry of Health in order to develop better and safer medicines, is starting a unique research project designed to reduce maternal and child mortality.

20 Jun 2007

Safe blood for safe motherhood

On the occasion of World Blood Donor Day, the theme of which this year is "Safe blood for safe motherhood", WHO is launching a new initiative to improve the availability and use of safe blood to save the lives of women during and after childbirth.

19 Jun 2007

New infectious diseases blueprint for action

New vaccines are available to make significant gains against cervical cancer deaths and debilitating pain from shingles, but infectious diseases experts warn that their full potential will not be realized without changes in the way vaccines for adults and adolescents are promoted, financed, and delivered in the United States.

19 Jun 2007

New Yorkers exposed to hepatitis C during surgery

Health authorities in New York are warning 4,500 people that they may have been exposed to hepatitis C.

18 Jun 2007

FDA scrutinise companies selling human tissue

Following an inspection blitz by the Food and Drug Administration (FDA) on companies which handle a variety of human material from deceased donors, no serious problems have apparently been unearthed.

13 Jun 2007

Cholera vaccine in a grain of rice

Japanese scientists have come up with a new strain of rice that carries a vaccine for cholera; they say the breakthrough will provide a cheaper and easier way of distributing the standard injection-based vaccine.

12 Jun 2007

Hepatitis C lookbacks

We can confirm that a review of patients' case notes in hospitals across England and Scotland has been carried out.

8 Jun 2007

Liver cancer drug Nexavar, a major breakthrough

A trial of an experimental drug to treat advanced liver cancer has helped extend patients lives by as much as three months.

4 Jun 2007

When HIV and liver disease co-exist

Since successful antiretroviral therapies have made HIV a treatable condition, more HIV patients who are also infected with hepatitis B or C are experiencing the progression of their liver disease.

3 Jun 2007

Liver cancer patients with high serum levels of hepatitis B virus face poorer outcomes

In the June issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD), researchers report their findings from the first-ever study examining the prognostic value of serum HBV DNA levels for patients with liver cancer undergoing chemotherapy.

3 Jun 2007